Effect of L/N-type Calcium Channel Blocker (Cilnidipine) on Oxidative Stress in Nitric Oxide-deficient Hypertensive Rats

被引:0
|
作者
Shaikh, Gouher B. [1 ]
Hippargi, Surekha [2 ]
Majid, Dewan S. A. [3 ]
Biradar, M. S. [4 ]
Das, Kusal K. [1 ]
机构
[1] Tulane Univ, Lab Vasc Physiol & Med, Dept Physiol, New Orleans, LA 70118 USA
[2] Tulane Univ, Dept Pathol, New Orleans, LA 70118 USA
[3] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA
[4] BLDE Deemed Be Univ, Shri BM Patil Med Coll Hosp & Res Ctr, Dept Med, Vijayapura 586103, Karnataka, India
关键词
Nitric Oxide Deficient Hypertension; Oxidative Stress; Mean Arterial Pressure; Malondialdehyde;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The sympathetic nervous system plays a major role on the renal function through the vasoactive system and the renin-angiotensin aldosterone system. Even though interest in the renal protective effects of sympathetic blocker has been increased, there are not much data to clarify this efficiency in nitric oxide deficient hypertensive rats. Aim and Objectives: To find out the effect of cilnidipine, L/N-type calcium channel blocker on oxidative stress of kidney in Nitric Oxide Synthase (NOS) inhibited experimental hypertensive rats. Material and Methods: Male Albino Wistar rats (n-24) were randomly allocated into four groups: Group 1 control received vehicle; Group 2 received Cilnidipine; Group 3 received N-G-nitro-L-Arginine Methyl Ester NAME) hydrochloride; Group 4 received L-NAME and Cilnidipine; All drugs are given orally for 4 weeks. Blood pressure was measured before and after intervention and twice during intervention for all the rats. On 29th day, blood was collected and animals were sacrificed and kidneys were collected. Serum and kidney tissue Malondialdehyde (MDA) levels are estimated. Results: The results demonstrate that there is a significant increase in Mean Arterial Pressure (MAP) in L-NAME treated rats compared to control group. Treatment with cilnidipine significantly decreases the MAP in Group 4 rats. We also demonstrated the significant elevated serum and kidney tissue MDA levels in L-NAME treated rats. Treatment with Cilnidipine reduced serum and kidney tissue MDA levels in Group 4 rats as compared to Group 3 rats. Conclusion: The results demonstrate that cilnidipine has suppressive effects against progressive renal injury as evidenced by decrease oxidative stress indicator MDA levels in NO deficient hypertensive rats. This effect is explained by the L/N type calcium channel inhibition of Cilnidipine, the L-type calcium channel blocking action lowers blood pressure and N-type calcium channel blocking action leads to suppression of the sympathetic nerve activity and renin-angiotensin aldosterone system.
引用
收藏
页码:73 / 80
页数:8
相关论文
共 50 条
  • [21] Tissue Specific Effects of Chronic Sustained Hypoxia on Oxidative Stress: Role of Cilnidipine, a Dual L/N Type Calcium Channel Blocker
    Bagali, Shrilaxmi
    Naikwadi, Akram
    Das, Kusal K.
    JOURNAL OF KRISHNA INSTITUTE OF MEDICAL SCIENCES UNIVERSITY, 2019, 8 (01) : 31 - 36
  • [22] Oral administration of cilnidipine to patients with hypertensive intracerebral hemorrhage in the acute stage: significance and role of an N-type calcium channel blocker
    Matsuno, A.
    Ide, F.
    Tanaka, H.
    Asano, S.
    Miyawaki, S.
    Uno, T.
    Tanaka, J.
    Nakaguchi, H.
    Sasaki, M.
    Murakami, M.
    Fuke, N.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2009, 178 (04) : 419 - 422
  • [23] Kidney adaptation in nitric oxide-deficient Wistar and spontaneously hypertensive rats
    Pereira, LMM
    Almeida, JR
    Mandarim-De-Lacerda, CA
    LIFE SCIENCES, 2004, 74 (11) : 1375 - 1386
  • [24] Oral administration of cilnidipine to patients with hypertensive intracerebral hemorrhage in the acute stage: significance and role of an N-type calcium channel blocker
    A. Matsuno
    F. Ide
    H. Tanaka
    S. Asano
    S. Miyawaki
    T. Uno
    J. Tanaka
    H. Nakaguchi
    M. Sasaki
    M. Murakami
    N. Fuke
    Irish Journal of Medical Science, 2009, 178 : 419 - 422
  • [25] L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats
    Toba, Hiroe
    Yoshida, Mamiko
    Tojo, Chisato
    Nakano, Arisa
    Oshima, Yuko
    Kojima, Yushi
    Noda, Kazuki
    Wang, Jiahong
    Kobara, Miyuki
    Nakata, Tetsuo
    HYPERTENSION RESEARCH, 2011, 34 (04) : 521 - 529
  • [26] The N-type and L-type calcium channel blocker cilnidipine suppresses renal injury in Dahl rats fed a high-salt diet
    Aritomi, Shizuka
    Koganei, Hajime
    Wagatsuma, Hirotaka
    Mitsui, Akira
    Ogawa, Tetsuya
    Nitta, Kosaku
    Konda, Tomoyuki
    HEART AND VESSELS, 2010, 25 (06) : 549 - 555
  • [27] Renoprotective Effect of the L/N-Type Calcium Channel Antagonist Cilnidipine on Puromycin Aminonucleoside-Induced Nephrosis in Rats
    Takashima, Kayoko
    Nishiyama, Chizuru
    Arisaka, Nobuhiko
    Takahashi, Tetsuaki
    Souma, Shinji
    Tsuda, Miyuki
    Hayashi, Morimichi
    Kasahara, Hiroko
    Kodama, Hirokazu
    Tamura, Toru
    Murakami, Makoto
    Kuroda, Junji
    Sato, Fumiyasu
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2009, 59 (02): : 79 - 85
  • [28] The N-type and L-type calcium channel blocker cilnidipine suppresses renal injury in Dahl rats fed a high-salt diet
    Shizuka Aritomi
    Hajime Koganei
    Hirotaka Wagatsuma
    Akira Mitsui
    Tetsuya Ogawa
    Kosaku Nitta
    Tomoyuki Konda
    Heart and Vessels, 2010, 25 : 549 - 555
  • [29] Comparison of the Anti-Hypertensive Effects of the L/N-Type Calcium Channel Antagonist Cilnidipine, and the L-Type Calcium Channel Antagonist Amlodipine in Hypertensive Patients with Cerebrovascular Disease
    Takei, Kazuo
    Araki, Nobuo
    Ohkubo, Takeshi
    Tamura, Naotoshi
    Yamamoto, Toshimasa
    Furuya, Daisuke
    Yanagisawa, Chiaki Takano
    Shimazu, Kunio
    INTERNAL MEDICINE, 2009, 48 (16) : 1357 - 1361
  • [30] Antianginal effects of L-type and N-type calcium channel blocker cilnidipine assessed using the vasopressin-induced experimental angina model of rats
    Saitoh, M
    Sugiyama, A
    Nakamura, Y
    Hashimoto, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 152P - 152P